Nuclear Medicine Market Size Research on Company Profiles with Sales, Revenue and Growth Analysis Report
Nuclear Medicine Market Size Research Report by Product Type (Diagnostic nuclear medicine and Therapeutic radiopharmaceuticals), Application (Diagnostic applications and Therapeutic applications), End-user (Hospitals & diagnostic centers, Research institutes, and Others), and Region–Global Forecast to 2023
Market Snapshot:
Market Research Future (MRFR)’s report highlights that the global Nuclear Medicine Market Size is likely to strike a CAGR of 6.2% during the forecast period 2018 to 2023. The valuation of the market is expected to witness a growth of USD 5.430 Bn by the end of 2023. The growth of the market is dictated by increasing incidences of target conditions such as Cardiovascular Diseases (CVD) and cancer. Furthermore, the exponentially growing geriatric population is poised to add to the patient pool. The rising inclination towards the use of radiopharmaceuticals for the treatment of geriatric population is prognosticated to generate significant demand for nuclear medicines in the foreseeable future.
The market looks lucrative and is expanding at a significant pace. It is anticipated to witness constant growth over the next couple of years owing to increasing applications, discoveries, etc. Nevertheless, the expensiveness of the radiopharmaceuticals and side effects related to radiation exposure remain impediments to the market proliferation.
The “Nuclear Medicine Market Size” In-Depth competition analysis of the major companies in the report, sector of the report includes the market depictions, requirements, and product portrayals, manufacture, competence, contact figures, cost, and revenue.
The Nuclear Medicine Market Size Free Growth Sample will provide valuable insight with an emphasis on the global market including some of the major players such As, Cardinal Health, GE Healthcare, Bayer, Bracco Imaging, Curium, Lantheus Medical Imaging, Nordion Inc., Advanced Accelerators Applications, Mallinckrodt Pharmaceuticals, Jubliant Lifesciences, and Medtronic plc.
Market Segmentation
By Product Type
- Diagnostic Nuclear Medicine
- SPECT Radiopharmaceuticals
- Pet Radiopharmaceuticals
- Therapeutic Radiopharmaceuticals
- Alpha Emitters
- Beta Emitters
- Brachytherapy Isotopes
By Application
- Diagnostic Applications
- SPECT Applications
- Pet Applications
- Therapeutic Applications
- Thyroid
- Bone Metastasis
- Endocrine Tumors
- Lymphoma
- Others
Nuclear Medicine Market Size Segment by Regions, regional analysis covers:
- North America(United States, Canada and Mexico)
- Europe(Germany, France, UK, Russia and Italy)
- Asia-Pacific(China, Japan, Korea, India and Southeast Asia)
- South America(Brazil, Argentina, Colombia etc.)
- Middle East and Africa(Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Access Complete Detailed TOC Research Report at https://www.marketresearchfuture.com/reports/nuclear-medicine-market-6674
The report also appraises the supervisory scenarios which affect various decisions in the market. With all the data congregated and scrutinized using SWOT analysis, there is a vibrant picture of the competitive scenario of the Global Nuclear Medicine Market Size. Openings for the future market growth were uncovered and preoccupied competitive threats also textured.
About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Contact:
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com
Comments
Post a Comment